Evaluating the effects of dexmedetomidine compared to propofol as adjunctive therapy in patients with alcohol withdrawal

References

• Mayo-SmithMFBeecherLHFischerTLManagement of alcohol withdrawal delirium: an evidence-based practice guidelineArch Intern Med2004164131405141215249349
   PubMedGoogle Scholar
• McKeonAFryeMADelantyNThe alcohol withdrawal syndromeJ Neurol Neurosurg Psychiatry20087985486217986499
   PubMed Web of Science ®Google Scholar
• HallWZadorDThe alcohol withdrawal syndromeLancet19973499069189719009217770
   PubMed Web of Science ®Google Scholar
• RamosRMalletTDiVittisACohenRPredictors of severity of alcohol withdrawal in hospitalized patientsJ Clin Med Res20135537638023976910
   PubMedGoogle Scholar
• TreimanDMGABAergic mechanisms in epilepsyEpilepsia200142Suppl 381211520315
   PubMed Web of Science ®Google Scholar
• RichardsGSchochPHaefelyWBenzodiazepine receptors: new vistasSemin Neurosci19913191203
   Google Scholar
• HackJBHoffmanRSNeslonLSResistant alcohol withdrawal: does an unexpectedly large sedative requirement identify these patients early?J Med Toxicol200622556018072114
   PubMedGoogle Scholar
• NolopKBNatowAUnprecedented sedative requirements during delirium tremensCrit Care Med19851342462473979072
   PubMed Web of Science ®Google Scholar
• LineaweaverWCAndersonKHingDNMassive doses of midazolam infusion for delirium tremens without respiratory depressionCrit Care Med19881632942953342636
   PubMed Web of Science ®Google Scholar
• KahnDRBarnhorstAVBourgeoisJAA case of alcohol withdrawal requiring 1,600 mg of lorazepam in 24 hoursCNS Spectr200914738538919773714
   PubMed Web of Science ®Google Scholar
• PandharipandePShintaniAPetersonJLorazepam is an independent risk factor for transitioning to delirium in intensive care unit patientsAnesthesiology20061041212616394685
   PubMed Web of Science ®Google Scholar
• PertuzziWTSleep in the intensive care unitPharmacotherapy2005255 pt 234S39S15899747
   PubMed Web of Science ®Google Scholar
• GommersDBakkerJMedications for analgesia and sedation in the intensive care unit: an overviewCrit Care200812Suppl 3S418495055
   PubMed Web of Science ®Google Scholar
• HallRISandhamDCardinalPPropofol vs midazolam for ICU sedation: a Canadian multicenter randomized trialChest20011191151115911296183
   PubMed Web of Science ®Google Scholar
• OstermannMEKeenanSPSeiferlingRASibbaldWJSedation in the intensive care unit: a systematic reviewJAMA2000283111451145910732935
   PubMed Web of Science ®Google Scholar
• KofkeWAAnesthetic management of the patient with epilepsy or prior seizuresCurr Opin Anaesthesiol201023339139920421790
   PubMed Web of Science ®Google Scholar
• MacKenzieSKapadiaFGrantISPropofol infusion for control of status epilepticusAnaesthesia19904512104310452278326
   PubMed Web of Science ®Google Scholar
• McCowanCMarikPRefractory delirium tremens treated with propofol: a case seriesCrit Care Med20002861781178410890619
   PubMed Web of Science ®Google Scholar
• CoomesTRSmithSWSuccessful use of propofol in refractory delirium tremensAnn Emerg Med19973068258289398785
   PubMed Web of Science ®Google Scholar
• TakeshitaJUse of propofol for alcohol withdrawal delirium: a case reportJ Clin Psychiatry200465113413514974494
   PubMed Web of Science ®Google Scholar
• SohrabyRAttridgeRLHughesDWUse of propofol-containing versus benzodiazepine regimens for alcohol withdrawal requiring mechanical ventilationAnn Pharmacother201448445646124436457
   PubMed Web of Science ®Google Scholar
• Precedex. [package insert]Lake Forest, ILHospira, Inc2012
   Google Scholar
• GerlachATMurphyCVDastaJFAn updated focused review of dexmedetomidine in adultsAnn Pharmacother200943122064207419934395
   PubMed Web of Science ®Google Scholar
• GertlerRBrownCMitchellDHSilviusENDexmedetomidine: a novel sedative-analgesic agentProc (Bayl Univ Med Cent)200114132116369581
   PubMedGoogle Scholar
• MuzykAJFowlerJANorwoodDKChilipkoARole of alpha2-agonists in the treatment of acute alcohol withdrawalAnn Pharmacother201145564965721521867
   PubMed Web of Science ®Google Scholar
• EbertTJHallJEBarneyJAUhrichTDColincoMDThe effects of increasing plasma concentrations of dexmedetomidine in humansAnesthesiology200093238239410910487
   PubMed Web of Science ®Google Scholar
• JakobSMRuokonenEGroundsRMDexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilationJAMA2012307111151116022436955
   PubMed Web of Science ®Google Scholar
• PandharipandePPPunBTHerrDLEffect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trialJAMA2007298222644265318073360
   PubMed Web of Science ®Google Scholar
• SiobalMSKalletRHKivettRHTangJFUse of dexmedetomidine to facilitate extubation in surgical intensive-care-unit patients who failed previous weaning attempts following prolonged mechanical ventilation: a pilot studyRespir Care200651549249616638158
   PubMed Web of Science ®Google Scholar
• HughesDWVanwertELeporiLAdamsBDPropofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patientAm J Emerg Med2014321112.e3112.e424075805
   PubMed Web of Science ®Google Scholar
• RaynerSGWeinertCRPengHJepsonSBroccardAFStudy institutionDexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICUAnn Intensive Care2012211222620986
   PubMed Web of Science ®Google Scholar
• DarroujJPuriNPrinceELomonacoASpevetzAGerberDRDexmedetomidine infusion as adjunctive therapy to benzodiazepines for acute alcohol withdrawalAnn Pharmacother200842111703170518780809
   PubMed Web of Science ®Google Scholar
• DemuroJPBotrosDGWirkowskiEHannaAFUse of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case seriesJ Anesth201226460160522584816
   PubMed Web of Science ®Google Scholar
• FrazeeENPersonettHALeungJGNelsonSDierkhisingRABauerPRInfluences of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patientsJ Crit Care201429229830224360597
   PubMed Web of Science ®Google Scholar
• RovasaloATohmoHAantaaRKettunenEPalojokiRDexmedetomidine as an adjunct in the treatment of alcohol withdrawal delirium: a case reportGen Hosp Psychiatry200628436236316814639
   PubMed Web of Science ®Google Scholar
• CrispoALDaleyMJPepinJLHarfordPHBrownCVComparison of clinical outcomes in non intubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepinesPharmacotherapy201434991091724898418
   PubMed Web of Science ®Google Scholar
• MuellerSWPreslaskiCRKiserTHA randomized, double-blind, placebo-controlled dose range study of dexmedetomidine as adjunctive therapy for alcohol withdrawalCrit Care Med20144251131113924351375
   PubMed Web of Science ®Google Scholar
• KaneSPBenzodiazepine equivalents conversion calculator. ClinCalc [Updated February 11, 2014]. Available from: http://clincalc.com/Benzodiazepine/Accessed April 23, 2014
   Google Scholar
• SavolaJMVirtanenRCentral alpha 2-adrenoreceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medomidineEur J Pharmacol199119521931991678707
   PubMed Web of Science ®Google Scholar
• FurstSRWeingerMBDexmedetomidine, a selective alpha 2-agonist, does not potentiate the cardiorespiratory depression of alfentanil in the ratAnesthesiology19907258828881971163
   PubMed Web of Science ®Google Scholar
• TobiasJDDexmedetomidine: are there going to be issues with prolonged administration?J Pediatr Pharmacol Ther20101514922477787
   PubMedGoogle Scholar
• BischoffPKochsEAlpha 2-agonists in anesthesia and intensive medicineAnasthesiol Intensivmed Nofallmed Schmerzther1993281212
   Google Scholar
• JaatinenPRiihiojaPHaapalinnaAHeinonenEKiianmaaKHervonenAPrevention of ethanol-induced sympathetic overactivity and degeneration be dexmedetomidineAlcohol19951254394468519439
   PubMed Web of Science ®Google Scholar
• HunterJCFontanaDJHedleyLRAssessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative, and hypothermic action of dexmedetomidine in transgenic miceBr J Pharmacol19971227133913449421280
   PubMed Web of Science ®Google Scholar
• Correa-SalesCRabinBCMazeMA hypnotic response to dexmedetomidine, an alpha 2 agonists, is mediated in the locus coeruleus in ratsAnesthesiology19927669489521350889
   PubMed Web of Science ®Google Scholar
• OrserBABertlikMWangLYMacDonaldJFInhibition by propofol (2,6 diisopropylphenol) of the N-methyl D-aspartate subtype of glutamate receptor in cultured hippocampal neuronsBr J Pharmacol19951162176117688528557
   PubMed Web of Science ®Google Scholar
• UchidaILiLYangJThe role of the GABA(A) receptor alpha1 subunit N-terminal extracellular domain in propofol potentiation of chloride currentNeuropharmacology199736161116219517432
   PubMed Web of Science ®Google Scholar
• HaraMKaiYIkemotoYPropofol activates GABA-A receptor-chloride ionophore complex in dissociated hippocampal pyramidal neurons of the ratAnesthesiology1993797817888214758
   PubMed Web of Science ®Google Scholar
• MarikPEVaronJThe management of status epilepticusChest2004126258259115302747
   PubMed Web of Science ®Google Scholar